Minerva Neurosciences (NERV) Enterprise Value (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.26% |
| Dec 31, 2025 | -565.25% |
| Sep 30, 2025 | 19.29% |
| Jun 30, 2025 | 11.74% |
| Mar 31, 2025 | 18.97% |
| Dec 31, 2024 | 19.40% |
| Sep 30, 2024 | 14.05% |
| Jun 30, 2024 | 11.28% |
| Mar 31, 2024 | 14.86% |
| Dec 31, 2023 | 12.75% |
| Sep 30, 2023 | 9.43% |
| Jun 30, 2023 | -43.85% |
| Mar 31, 2023 | -4.10% |
| Dec 31, 2022 | 14.04% |
| Sep 30, 2022 | 19.12% |
| Jun 30, 2022 | 9.43% |
| Mar 31, 2022 | -1.74% |
| Dec 31, 2021 | 17.64% |
| Sep 30, 2021 | 11.61% |
| Jun 30, 2021 | 7.38% |
| Mar 31, 2021 | -215.20% |
| Dec 31, 2020 | 21.95% |
| Sep 30, 2020 | -0.82% |
| Jun 30, 2020 | -7.35% |
| Mar 31, 2020 | 34.28% |
| Dec 31, 2019 | -20.65% |
| Sep 30, 2019 | -36.00% |
| Jun 30, 2019 | 9.00% |
| Mar 31, 2019 | 38.99% |
| Dec 31, 2018 | 42.41% |
| Sep 30, 2018 | -27.05% |
| Jun 30, 2018 | -52.10% |
| Mar 31, 2018 | 64.71% |
| Dec 31, 2017 | -32.46% |
| Sep 30, 2017 | -24.73% |
| Jun 30, 2017 | -368.87% |
| Mar 31, 2017 | 80.06% |
| Dec 31, 2016 | 9.66% |
| Sep 30, 2016 | 5.36% |
| Jun 30, 2016 | -117.42% |
| Mar 31, 2016 | -38.61% |
| Dec 31, 2015 | 14.09% |
| Sep 30, 2015 | -5.94% |
| Jun 30, 2015 | 32.21% |
| Mar 31, 2015 | -181.47% |
| Dec 31, 2014 | 21.55% |
| Sep 30, 2014 | -4,824.82% |
| Jun 30, 2014 | 77.58% |
| Mar 31, 2014 | -17.76% |
| Dec 31, 2013 | -65.26% |
| Sep 30, 2013 | 25.76% |